A major distribution agreement that will see NZ software used in hospitals and laboratories around the world was
announced today.
New Zealand owned and operated software and e-commerce systems developer/exporter Delphic Medical Systems has recently
signed a distribution agreement with Japanese medical giant, Sysmex. The agreement will guarantee New Zealand company
Delphic, which produces highly innovative “across the net” medical laboratory software, total access to the US and
European markets, piggybacking on the international Sysmex name.
“This is a huge coup for a New Zealand company,” says Mark Cox , Business Development Manager of Delphic Medical
Systems. “Our export market was steadily growing but this agreement with Sysmex puts it on a global fast track.”
Sysmex is a public company, listed on the Tokyo Stock Exchange, with a turnover of US$340 million per annum. Sysmex
Corporation, and its operating companies, such as Sysmex InfoSystems America, Sysmex Europe and Sysmex UK are a leading
global manufacturer and marketer of diagnostic instrument and information systems which automatically test blood and
urine for disease. Leadership positions include laboratory Hematology robotic Systems, where Sysmex has captured 95% of
the global market share.
Announcing the agreement, President of Sysmex Mr Hisashi Ietsugu said: “This is in line with our strategy to establish a
firm reputation in medical software. Delphic is a small but highly innovative company, which has demonstrated its
ability to create leading edge technology. We are very pleased to have this association with them.”
Sysmex has offices in the UK, USA, France, Belgium and Germany, all highly profitable export markets with great
potential for Delphic’s software products.
“Delphic are expecting massive growth in sales of “Delphic AP” and “Éclair” - now that Sysmex have opened the door to
Europe and the US. Sysmex predicts that sales of the two products will grow to US$6 million within three years. This
will mean increasing our employee numbers in New Zealand. It will also secure the global positioning of our company,
already regarded as a leader in innovative software development for this sector,” says Mr Cox.
Delphic is a private company currently employing 42 people. It has already sold its Delphic AP (Anatomical Pathology)
and Eclair software systems throughout New Zealand, and to sites in Australia, Singapore, USA and Holland.
Delphic AP, installed in community laboratories and in hospitals, is based on the latest version of Lotus Notes. It is
part of a suite of software that provides an entirely electronic environment for reporting pathology results to
referring doctors. The software interfaces with laboratory equipment, and generates reports about patients’ conditions
for doctors.
The Eclair software suite is a first step hospitals can take to electronic medical records. It interfaces with Delphic
AP – and other software systems – and is literally an “Electronic Clinical Information Repository” (Eclair)”. It is used
for radiology and pathology reporting. Eclair allows patients’ results to be available on computer for doctors who need
them, without generating paper. It permits hospitals to see lab results the moment they are done, rather than hours or
days after ordering. Eclair is designed to be used on an intranet, and can also deliver results remotely across the
Worldwide Web.
Although Delphic Medical Systems has been very successful in exporting its systems and in introducing them to other
countries, the company found it needed to have a sales presence constantly in the US and Europe to really succeed.
“Through this deal, Delphic will grow in importance internationally. To give an idea of scale: in New Zealand there are
40 to 50 medical laboratories. In the USA there are 92,000 and around the same number in Europe,” says Mr Cox. “We
needed to increase our scale to be competitive. We couldn’t achieve that easily without a distributor. Sysmex was the
ideal partner. Their global growth strategy was a perfect fit with Delphic’s worldwide product vision.”
Mr Cox says Sysmex was attracted to Delphic because of the quality of its software, and its history of innovation.
“Our people have a unique mix of laboratory and IT backgrounds. As a result, our systems are robust, intuitive and
developed with a good understanding of what the customer needs. Delphic is able to interact well with top quality
medical institutions in New Zealand. This provides us and Sysmex with a strong environment for developing global
software to a high standard. We can trial and test our products, and continue to develop them alongside the very
professionals who use them,” he says.
“We’re currently supplying software in many other languages, and we have the advantage that New Zealand is an excellent,
cohesive market in which to innovate new product adaptations.”
Delphic Medical Systems Limited is based in Auckland. It was founded 14 years ago by software pioneers James Webster and
Roger Seaton, both of whom continue to create software for the company.
A key aim of the company is to create software that allows integration of information and records between primary,
secondary and tertiary healthcare – or doctors, clinics and hospitals – at the click of a mouse. Delphic is also known
for its New Zealand developed product WHOOSH, an on-line management system for safety and health systems. WHOOSH is also
being developed offshore to help users in other countries manage their work safety and health needs.
Ends
For more information, Please contact: Mark Cox Phone (09) 630 3554
Mobile – 021 647 251
Released on behalf of Delphic by PRaxis Public Relations Limited: Catherine Peters Phone (09) 373-5068; mobile (025)
748-273
www.Delphic.co.nz